title: Risk factors associated with linezolid-nonsusceptible enterococcal infections.
abstract: Linezolid is one of few treatment options available for vancomycin-resistant enterococci. The present study investigated risk factors for linezolid-nonsusceptible enterococci using a case-control study of 15 cases and 60 control patients. Previous hospitalization, admission to a medical service, comorbidity, and linezolid and sulfonamide therapy were identified as risk factors.
authors.affiliation: College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR 97239, USA. mcgregoj@ohsu.edu
authors.forename: Jessina C
authors.initials: JC
authors.lastname: McGregor
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Hartung
authors.forename: George P
authors.initials: GP
authors.lastname: Allen
authors.forename: Randy A
authors.initials: RA
authors.lastname: Taplitz
authors.forename: Robin
authors.initials: R
authors.lastname: Traver
authors.forename: Tony
authors.initials: T
authors.lastname: Tong
authors.forename: David T
authors.initials: DT
authors.lastname: Bearden
mesh_terms: D000081:Acetamides / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016022:Case-Control Studies; D024881:Drug Resistance, Bacterial; D016983:Enterococcus / Q000187:drug effects / Q000302:isolation & purification*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000494:pharmacology*; D012307:Risk Factors
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid